Moloney Securities Asset Management LLC lessened its stake in shares of Colgate-Palmolive (NYSE:CL) by 43.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,146 shares of the company’s stock after selling 4,694 shares during the period. Moloney Securities Asset Management LLC’s holdings in Colgate-Palmolive were worth $423,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Retirement Income Solutions Inc increased its holdings in shares of Colgate-Palmolive by 5.5% in the 3rd quarter. Retirement Income Solutions Inc now owns 10,067 shares of the company’s stock valued at $740,000 after purchasing an additional 524 shares during the period. Schulhoff & Co. Inc. acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at about $406,000. LGT Capital Partners LTD. increased its holdings in shares of Colgate-Palmolive by 73.7% in the 4th quarter. LGT Capital Partners LTD. now owns 1,244,480 shares of the company’s stock valued at $85,670,000 after purchasing an additional 527,860 shares during the period. BlackRock Inc. increased its holdings in shares of Colgate-Palmolive by 0.5% in the 2nd quarter. BlackRock Inc. now owns 60,205,815 shares of the company’s stock valued at $4,314,949,000 after purchasing an additional 279,887 shares during the period. Finally, Mosaic Family Wealth LLC increased its holdings in shares of Colgate-Palmolive by 4.5% in the 3rd quarter. Mosaic Family Wealth LLC now owns 4,833 shares of the company’s stock valued at $355,000 after purchasing an additional 206 shares during the period. Hedge funds and other institutional investors own 76.79% of the company’s stock.
A number of equities analysts have recently weighed in on the company. Atlantic Securities upgraded Colgate-Palmolive from a “neutral” rating to an “overweight” rating in a report on Monday, February 3rd. SunTrust Banks reiterated a “hold” rating and issued a $70.00 target price on shares of Colgate-Palmolive in a report on Monday, February 3rd. Bank of America downgraded Colgate-Palmolive from a “buy” rating to a “neutral” rating and dropped their target price for the company from $77.00 to $74.00 in a report on Thursday, December 19th. ValuEngine upgraded Colgate-Palmolive from a “sell” rating to a “hold” rating in a report on Thursday, November 14th. Finally, Deutsche Bank increased their price objective on Colgate-Palmolive from $72.00 to $73.00 and gave the stock a “hold” rating in a report on Thursday, December 12th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and six have assigned a buy rating to the company’s stock. Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $75.00.
NYSE:CL opened at $76.69 on Friday. The stock’s 50 day moving average price is $71.32 and its 200 day moving average price is $70.33. Colgate-Palmolive has a 52 week low of $64.75 and a 52 week high of $77.41. The company has a market capitalization of $65.45 billion, a P/E ratio of 26.99, a P/E/G ratio of 5.48 and a beta of 0.71. The company has a debt-to-equity ratio of 43.94, a quick ratio of 0.24 and a current ratio of 0.37.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.73 EPS for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a return on equity of 1,906.25% and a net margin of 15.08%. The firm had revenue of $4.02 billion for the quarter, compared to the consensus estimate of $3.93 billion. During the same quarter in the prior year, the company posted $0.74 earnings per share. The firm’s revenue was up 5.4% on a year-over-year basis. As a group, sell-side analysts forecast that Colgate-Palmolive will post 2.98 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Thursday, January 23rd were issued a $0.43 dividend. The ex-dividend date of this dividend was Wednesday, January 22nd. This represents a $1.72 dividend on an annualized basis and a yield of 2.24%. Colgate-Palmolive’s dividend payout ratio is currently 60.78%.
In other Colgate-Palmolive news, Director Helene D. Gayle sold 22,240 shares of the company’s stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $76.08, for a total transaction of $1,692,019.20. Following the completion of the sale, the director now owns 22,473 shares of the company’s stock, valued at $1,709,745.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Ian M. Cook sold 16,000 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $66.70, for a total value of $1,067,200.00. Following the sale, the chairman now directly owns 1,099,361 shares of the company’s stock, valued at approximately $73,327,378.70. The disclosure for this sale can be found here. Insiders have sold 216,590 shares of company stock valued at $15,999,488 in the last ninety days. Company insiders own 1.14% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Read More: What is a stock buyback?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.